First of all, a particular drug can have many indications in many diseases. If it was for diabetes, it would go through the CDR, but if it's for cancer, let's say cancer of the left ear, it would go to JODR. The funding for each individual indication is the responsibility of the province, right? So they may pay for drug X for disease Y but not drug X for disease Z. They base the evidence proving the drug is effective--
On April 30th, 2007. See this statement in context.